AgentV’s Virtues at the Vanguard of Extracellular Vesicles July 31, 2024 BioEconomy, Biomanufacturing, Bioprocessing, Exosomes / Extracellular Vesicles
Leaving Flatland Behind – A View from Experience in 3D Adherent Cell Culture for Advanced Therapies June 18, 2024 Biomanufacturing, Bioprocessing
A Picture is Worth a Thousand Person-Hours: Get to Know RoosterBio April 15, 2024 Biomanufacturing, Corporate
Four New Companies Working to Thread an Improved Triangular Needle for Better, Cheaper, & Faster… October 11, 2023 BioEconomy, Biomanufacturing
From Elephant Ears to Ambr® Waves: A New Path Toward Scale & Abundance for Biomanufactured hMSCs… October 03, 2022 Biomanufacturing, Exosomes / Extracellular Vesicles, MSCs & Characterization
Versatile Manufacturing Formats for Your Adherent Cell Therapy “Triathlon” & Its Bioprocess… August 25, 2022 Biomanufacturing, Bioprocessing
Extracellular Vesicle/Exosome Upstream Process Development: Maximizing Productivity to Accelerate… April 01, 2022 Biomanufacturing, Exosomes / Extracellular Vesicles
Maintaining CQAs as Manufacturing Processes are Scaled from 2D to 3D Bioreactor Culture February 28, 2022 Biomanufacturing, Quality & Regulatory
MSCs “Versus” or MSCs “Via” T Cells for Cell & Gene Therapy? February 07, 2022 Biomanufacturing, Cell Therapy
